3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Melanoma
2
Glioblastoma
2
Brain Neoplasms
2
Advanced Solid Tumor
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ulnar Neuropathies
1
Triple Negative Breast Neoplasms
1
Solid Tumor, Adult
1
Prostatic Hyperplasia
1
Peripheral Lung Tumor
1
Pain
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Squamous Lung Cancer
1
Neuroma
1
Multiple Myeloma
1
Mucositis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leiomyoma
1
Keratosis, Actinic
1
Hyperthermia
1
Glioma
1
Interventions
telapristone acetate
18
vilaprisan
12
relugolix
11
estradiol, norethindrone drug combination
9
asoprisnil
9
Estradiol
8
elagolix
7
Uterine Myomectomy
7
ulipristal acetate
6
Norethindrone Acetate
6
Leuprolide
5
linzagolix
4
Uterine Artery Embolization
3
Sugars
3
ulipristal
2
Progestins
2
Mifepristone
2
epigallocatechin gallate
1
carbetocin
1
Vitamin D
1
Vitamin B 6
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Radiofrequency Ablation
1
Progesterone
1
Microbial Collagenase
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Leiomyoma
×
Therapeutics
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts